Overall survival benefits of first-line treatments for asian patients with advanced epidermal growth factor receptor-mutated nsclc harboring exon 19 deletion: a systematic review and network meta-analysis

HIGHLIGHTS

• who: Sik-Kwan Chan and colleagues from the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China have published the Article: Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis, in the Journal: (JOURNAL) of 30/04/2022
• what: This research has been recorded in the Prospective Register of Systematic Reviews (CRD 42022320833).
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.